Diligence memo · auto-generated · as of July 1, 2026

PreDxion Bio

PreDxion Bio: limited disclosed financing to assess.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

PreDxion Bio operates in Hardware / Semiconductors, based in South San Francisco, CA, USA. Rapid, scalable diagnostic for SARS-CoV-2 and beyond

Sub-sector tags: COVID-19, Microfluidics, Nanosensors, hardware/semi.

Capital & rounds (filed)filed

PreDxion Bio has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.

Valuation (modeled)modeled

No modeled valuation — too little disclosed financing to estimate one.

Financing rhythm & timingmixed

Not enough dated financing history to read a financing rhythm.

Comparablesmixed

Capital scale ranks ahead of 48% of Hardware / Semiconductors peers (130 compared).

Modeled value ranks above 48% of those peers.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.